Synovial Tissue Heterogeneity and Peripheral Blood Biomarkers
- 379 Downloads
Rheumatoid arthritis is characterized by multiple pathobiological processes and heterogeneous clinical phenotypes. Not surprisingly, the inflamed synovium harbors an equally complex pathology. This includes variability in infiltrating and resident cell populations, spatial arrangements, and cell–cell interactions, as well as gene expression profiles. Remarkable progress in our understanding of the many facets of tissue heterogeneity has been facilitated by the increasing availability of patients’ material and the development of advanced research technologies. The next challenge is to capitalize on the large amount of data generated to elucidate the specific pathogenic pathways disparately activated in different patients and/or different phases of the disease. When tissue pathology can be reliably explored through noninvasive circulating biomarkers, then the circle will be closed. We attempt to highlight key advances in the understanding of synovial tissue heterogeneity in rheumatoid arthritis and summarize novel perspectives in synovial biomarker discovery in relation to peripheral blood.
KeywordsRheumatoid arthritis Synovial membrane Synovial tissue Heterogeneity Peripheral blood Biomarker
No potential conflicts of interest relevant to this article were reported.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 7.van de Sande MG, Thurlings RM, Boumans MJ, et al. Presence of lymphocyte aggregates in the synovium of patients with early arthritis in relationship to diagnosis and outcome: is it a constant feature over time? Ann Rheum Dis. 2010. doi: 10.1136/ard.2010.139287.
- 11.Barrera P, Joosten LA, den Broeder AA, van de Putte LB, van Riel PL, van den Berg WB. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis. Ann Rheum Dis. 2001;60:660–9.PubMedCrossRefGoogle Scholar
- 20.• van de Sande MG, de Hair MJ, van der Leij C, et al: Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 2010, doi: 10.1136/ard.2010.139527. This work is the first to investigate the pathological features of the synovial membrane in nonarthritic individuals at risk of developing RA. Availability of synovial tissue from unaffected joints is allowed by mini-invasive small-bore arthroscopy of the knee.
- 22.van der Pouw Kraan TC, van Gaalen FA, Huizinga TW, et al. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun. 2003;4:187–96.PubMedCrossRefGoogle Scholar
- 26.van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, van Laar JM. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum. 2008;58:53–60.PubMedCrossRefGoogle Scholar
- 29.Wijbrandts CA, Vergunst CE, Haringman JJ, Gerlag DM, Smeets TJ, Tak PP. Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: implications for use of synovial sublining macrophages as a biomarker. Arthritis Rheum. 2007;56:3869–71.PubMedCrossRefGoogle Scholar
- 33.Kasperkovitz PV, Timmer TC, Smeets TJ, et al. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum. 2005;52:430–41.PubMedCrossRefGoogle Scholar
- 35.Tolboom TC, van der Helm-Van Mil AH, Nelissen RG, Breedveld FC, Toes RE, Huizinga TW. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum. 2005;52:1999–2002.PubMedCrossRefGoogle Scholar
- 38.Bradfield PF, Amft N, Vernon-Wilson E, et al. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum. 2003;48:2472–82.PubMedCrossRefGoogle Scholar
- 39.Timmer TC, Baltus B, Vondenhoff M, et al. Inflammation and ectopic lymphoid strucutes in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum. 2007;56:2492–502.PubMedCrossRefGoogle Scholar
- 46.Bugatti S, Manzo A, Vitolo B, et al. Clinical, radiographic and biomolecular features of B cell synovitis in rheumatoid arthritis. Arthritis Rheum. 2010;62:S260 [abstract].Google Scholar
- 47.•• Humby F, Bombardieri M, Manzo A, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009;6:e1. The authors took advantage of a combined in vivo and ex vivo approach to demonstrate the functionality of synovial B-cell follicles in RA. They showed that B cells in the context of large lymphoid aggregates express AID, the key enzyme required for somatic hypermutation and class-switch recombination of the immunoglobulin genes, and support the production of ACPA antibodies when xenotransplanted into SCID mice.PubMedCrossRefGoogle Scholar
- 48.•• Scheel T, Gursche A, zacher J, Häupl T, Berek C. V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion with accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum. 2011;63:63–72. This work aimed to identify the clonality of B cells and plasma cells within RA synovial tissues. Through laser capture microdissection of B cells and plasma cells and Ig VH gene sequencing, the authors elegantly demonstrated that plasma cells are clonally related to B cells, thus providing evidence of the local differentiation of B cells.PubMedCrossRefGoogle Scholar
- 56.Crotti TN, Smith MD, Weedon H, et al. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis. 2002;61:1047–54.PubMedCrossRefGoogle Scholar
- 60.Klareskog L, Malmström V, Lundberg K, Padyukov L, Alfredsson L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol. 2011. doi: 10.1016/j.smim.2011.01.014.
- 62.Rooney T, Roux-Lombard P, Veale DJ, FitzGerald O, Dayer JM, Bresnihan B. Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade. Ann Rheum Dis. 2010;69:706–14.PubMedCrossRefGoogle Scholar
- 63.•• van Baarsen LG, Wijbrandts CA, Timmer TC, van der Pouw Kraan TC, Tak PP, Verweij CL. Synovial tissue heterogeneity in rheumatoid arthritis in relation to disease activity and biomarkers in peripheral blood. Arthritis Rheum. 2010;62:1602–7. This important work opens the avenue for comparative synovial–peripheral blood profiling in RA. The authors analyzed extensive gene expression of paired synovial tissue biopsies and whole peripheral blood using complementary DNA microarrays. Although the work failed to highlight significant overlap, it provides the rationale for further studies focused on specific peripheral blood cell populations or molecular pathways.PubMedCrossRefGoogle Scholar
- 66.Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, et al. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. Arthritis Rheum. 2008;58:2257–67.PubMedCrossRefGoogle Scholar
- 67.Mao Y, Wang M, Zhou Q, et al. CXCL10 and CXCL13 expression were highly up-regulated in peripheral blood mononuclear cells in acute rejection and poor response to anti-rejection therapy. J Clin Immunol. 2010. doi: 10.1007/s10875-010-9500-8.